Company Filing History:
1 out of 14 
1 out of 10 Years Active: 2012
Title: Choul Hong Park: Innovator in Thiazolidinone Derivatives
Introduction
Choul Hong Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly through his work on thiazolidinone derivatives. His innovative approach has led to advancements in the understanding and application of these compounds.
Latest Patents
Choul Hong Park holds a patent for a thiazolidinone derivative, which aims to provide novel compounds with a CDC7 inhibitory action. The patent details compounds that inhibit the CDC7 protein kinase activity, thereby suppressing cell proliferation. This innovation has potential implications in cancer research and treatment.
Career Highlights
Throughout his career, Choul Hong Park has worked with various companies, including Sbi Biotech Co., Ltd. and Crystalgenomics, Inc. His experience in these organizations has allowed him to develop and refine his expertise in biochemistry and pharmacology.
Collaborations
Choul Hong Park has collaborated with notable professionals in his field, including Takayuki Irie and Masaaki Sawa. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Choul Hong Park is a distinguished inventor whose work on thiazolidinone derivatives has the potential to impact the medical field significantly. His innovative contributions and collaborations highlight his commitment to advancing scientific knowledge and therapeutic applications.